BioLife Solutions (BLFS) Misses Q3 EPS by 31c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.25 -0.79%
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.67), $0.31 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $33.01 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
